The 12 November press release about the Molecular and Cellular Neurobiotechnology group's research on inhibitory molecules in neuroregeneration, 'Beating the regeneration blockers', was picked up by various online scientific and health news sites including www.sciencedaily.com, the UK's MS Trust and Cell DNA.
http://www.medicalnewstoday.com/articles/207788.php
http://www.thisisms.com/ftopict-14586-.html
http://www.msnews.com/multiple-sclerosis/regeneration-blockers-may-affect-myelin-levels/